Related Experiment Video

Updated: Apr 16, 2026

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

2.2K

[Endovascular treatment for chronic coronary occlusions in patients with coronary heart disease]

R O Shirokov, A N Samko, B I Milen'kin

    Vestnik Rentgenologii I Radiologii
    |March 18, 2015
    PubMed

    Insights

    Endovascular treatment successfully restored blood flow in 72.1% of patients with chronic coronary occlusions. Physician experience and occlusion characteristics significantly impact success rates for this safe and effective procedure.

    Area of Science:

    • Cardiovascular Medicine
    • Interventional Cardiology
    • Vascular Surgery

    Background:

    • Chronic coronary occlusions (CCOs) represent a significant challenge in managing coronary heart disease (CHD).
    • Endovascular techniques offer a minimally invasive approach to revascularize these complex lesions.

    Purpose of the Study:

    • To evaluate the angiographic outcomes of endovascular treatment for CCOs in patients with CHD.
    • To identify factors influencing the success of recanalization procedures.

    Main Methods:

    • A cohort of 854 patients with CHD and CCOs underwent attempted endovascular recanalization between 2009 and 2013.
    • Data collected included patient demographics, occlusion characteristics (duration, morphology, TIMI grade), and procedural success rates.

    Main Results:

    • Successful recanalization was achieved in 616 (72.1%) patients.
    • Recanalization failure occurred in 238 (27.9%) patients.
    • Factors such as occlusion duration, morphological characteristics, and operator experience were found to influence procedural success.

    Conclusions:

    • Endovascular recanalization of CCOs is a highly effective and relatively safe therapeutic option.
    • Optimizing procedural success requires careful consideration of occlusion complexity and operator expertise.
    Abstract

    More Related Videos

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

    Published on: May 14, 2013

    26.6K
    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    12.8K

    Related Concept Videos

    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    435
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    623
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    498
    Aneurysm III: Interprofessional Care01:26

    Aneurysm III: Interprofessional Care

    Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
    463
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    452
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    621